Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence

Shamar Young, Jafar Golzarian, J. Kyle Anderson

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Renal cell carcinoma (RCC) is most commonly diagnosed at an early (T1a) stage and is typically amenable to several effective treatments. The current gold standard therapy is partial nephrectomy, given its decreased morbidity and similar oncologic outcomes when compared with radical nephrectomy. Thermal ablation is an evolving definitive therapy for T1a RCC which is even less invasive than partial nephrectomy. This article reviews the evidence for thermal ablation in the treatment of T1a RCC and compares outcomes of existing ablation modalities with surgical management.

Original languageEnglish (US)
Pages (from-to)367-373
Number of pages7
JournalSeminars in Interventional Radiology
Issue number5
StatePublished - 2019

Bibliographical note

Publisher Copyright:
© 2019 Georg Thieme Verlag. All rights reserved.


  • cryoablation
  • microwave ablation
  • partial nephrectomy
  • radiofrequency ablation
  • renal cell carcinoma
  • thermal ablation


Dive into the research topics of 'Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence'. Together they form a unique fingerprint.

Cite this